In Brief

The mindfulness app is creating meditation programs that will target and specific mental and physical conditions, pioneering the use of digital healthcare to help people achieve their goals

The known benefits of meditation range from quelling anxiety and depression to lowering blood pressure. Headspace, the million-dollar mindfulness service, is taking applications of the calming practice to the next level, expanding its programs to offer prescription-strength, focused meditation sessions to treat a variety of health issues.

The meditation app will begin clinical trials this summer to test the benefits of the meditation tools made available through what it is calling Headspace Health, a program focused on integrating meditation with healthcare. Through the trials, Headspace hopes to gain approval from the Food and Drug Administration (FDA) for the digital health initiatives slated to be released in 2020.

While Headspace hasn’t released any details on exactly which ailments, either physical or mental, it plans to target, Headspace’s team maintains that it is currently taking aim at treating a dozen different conditions using guided meditations. The app intends to pioneer the use of digital health to better enable mindful health practices as they continue to increase in popularity among consumers.

Headspace


Lead image: woman relaxing with headphones on stock photo from Stock-Asso/Shutterstock

The known benefits of meditation range from quelling anxiety and depression to lowering blood pressure. Headspace, the million-dollar mindfulness service, is taking applications of the calming practice to the next level, expanding its programs to offer prescription-strength, focused meditation sessions to treat a variety of health issues.

The meditation app will begin clinical trials this summer to test the benefits of the meditation tools made available through what it is calling Headspace Health, a program focused on integrating meditation with healthcare. Through the trials, Headspace hopes to gain approval from the Food and Drug Administration (FDA) for the digital health initiatives slated to be released in 2020.